Biomarkers in Diagnostic Genitourinary Pathology

Biomarkers in Diagnostic Genitourinary Pathology is organized by Opus Medicus, Inc.

Course Dates:
Last Review Date: 21-Nov-2018
Expiration Date: 20-Nov-2021

Credits
AMA PRA Category 1 Credits™
Opus Medicus designates this Internet enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Maintenance of Certification (MOC) Credits
In addition to AMA PRA Category 1 Credits™, Opus Medicus designates this course for Specialty Board
MOC Program Credits:
1.25 ABP SAM for MOC/CC Credits1

Description:
This course employs a case-based approach to illustrate the application of new biomarkers as an adjunct to histomorphologic features for diagnosing renal infiltrative tumors, bladder urothelial carcinoma, and testicular germ cell tumors.

Topics:
• Primary lymphoma of the kidney.
• Differential Diagnosis of infiltrative renal neoplasms.
• Diagnostic significance of PAX8 positivity.
• Flat lesions of the bladder urothelium.
• Papillary urothelial carcinoma.
• Urothelial carcinoma in situ.
• Stathmin1 and its diagnostic significance.
• Germ cell tumors of the testis.
• New biomarkers for embryonal versus choriocarcnoma.
• GATA3 expression in germ cell tumors.

Objectives:
After completing this course, physicians are expected to improve their understanding of:
• How to approach differential diagnoses in GU pathology practically based on H&E evaluation.
• How a practical and select panel of biomarkers can be used to confirm one's H&E impression.
• Differential diagnoses and how biomarkers can help to confirm or exclude diagnostic considerations in GU pathology.